Berberine Ameliorates Obesity by Inducing GDF15 Secretion by Brown Adipocytes

Endocrinology. 2023 Feb 11;164(4):bqad035. doi: 10.1210/endocr/bqad035.

Abstract

Berberine (BBR), which is a compound derived from the Chinese medicinal plant Coptis chinensis, promotes weight loss, but the molecular mechanisms are not well understood. Here, we show that BBR increases the serum level of growth differentiation factor 15 (GDF15), which is a stress response cytokine that can reduce food intake and lower body weight in diet-induced obese (DIO) mice. The body weight and food intake of DIO mice were decreased after BBR treatment, and the weight change was negatively correlated with the serum GDF15 level. Further studies show that BBR induced GDF15 mRNA expression and secretion in the brown adipose tissue (BAT) of DIO mice and primary mouse brown adipocytes. In addition, we found that BBR upregulates GDF15 mRNA expression and secretion by activating the integrated stress response (ISR) in primary mouse brown adipocytes. Overall, our findings show that BBR lowers body weight by inducing GDF15 secretion via the activation of the ISR in BAT.

Keywords: GDF15; berberine; brown adipocytes; integrated stress response; obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes, Brown* / metabolism
  • Adipose Tissue, Brown / metabolism
  • Animals
  • Berberine* / metabolism
  • Berberine* / pharmacology
  • Body Weight
  • Growth Differentiation Factor 15 / genetics
  • Mice
  • Obesity / metabolism
  • RNA, Messenger / metabolism

Substances

  • Berberine
  • Growth Differentiation Factor 15
  • RNA, Messenger